Pharmacology of the lower urinary tract: basis for current and future treatments of urinary incontinence
- PMID: 15602011
- DOI: 10.1124/pr.56.4.4
Pharmacology of the lower urinary tract: basis for current and future treatments of urinary incontinence
Abstract
The lower urinary tract constitutes a functional unit controlled by a complex interplay between the central and peripheral nervous systems and local regulatory factors. In the adult, micturition is controlled by a spinobulbospinal reflex, which is under suprapontine control. Several central nervous system transmitters can modulate voiding, as well as, potentially, drugs affecting voiding; for example, noradrenaline, GABA, or dopamine receptors and mechanisms may be therapeutically useful. Peripherally, lower urinary tract function is dependent on the concerted action of the smooth and striated muscles of the urinary bladder, urethra, and periurethral region. Various neurotransmitters, including acetylcholine, noradrenaline, adenosine triphosphate, nitric oxide, and neuropeptides, have been implicated in this neural regulation. Muscarinic receptors mediate normal bladder contraction as well as at least the main part of contraction in the overactive bladder. Disorders of micturition can roughly be classified as disturbances of storage or disturbances of emptying. Failure to store urine may lead to various forms of incontinence, the main forms of which are urge and stress incontinence. The etiology and pathophysiology of these disorders remain incompletely known, which is reflected in the fact that current drug treatment includes a relatively small number of more or less well-documented alternatives. Antimuscarinics are the main-stay of pharmacological treatment of the overactive bladder syndrome, which is characterized by urgency, frequency, and urge incontinence. Accepted drug treatments of stress incontinence are currently scarce, but new alternatives are emerging. New targets for control of micturition are being defined, but further research is needed to advance the pharmacological treatment of micturition disorders.
Similar articles
-
Therapeutic receptor targets for lower urinary tract dysfunction.Naunyn Schmiedebergs Arch Pharmacol. 2008 Jun;377(4-6):437-48. doi: 10.1007/s00210-007-0209-z. Epub 2007 Nov 21. Naunyn Schmiedebergs Arch Pharmacol. 2008. PMID: 18034230 Review.
-
[New insights into neural mechanisms controlling the micturition reflex].Nihon Yakurigaku Zasshi. 2003 May;121(5):290-8. doi: 10.1254/fpj.121.290. Nihon Yakurigaku Zasshi. 2003. PMID: 12784730 Review. Japanese.
-
Pharmacology of the lower urinary tract.Annu Rev Pharmacol Toxicol. 2001;41:691-721. doi: 10.1146/annurev.pharmtox.41.1.691. Annu Rev Pharmacol Toxicol. 2001. PMID: 11264473 Review.
-
The basis for drug treatment of the overactive bladder.World J Urol. 2001 Nov;19(5):294-8. doi: 10.1007/pl00007101. World J Urol. 2001. PMID: 11760776 Review.
-
Integrative control of the lower urinary tract: preclinical perspective.Br J Pharmacol. 2006 Feb;147 Suppl 2(Suppl 2):S25-40. doi: 10.1038/sj.bjp.0706604. Br J Pharmacol. 2006. PMID: 16465182 Free PMC article. Review.
Cited by
-
Protection against 1,2-di-methylhydrazine-induced systemic oxidative stress and altered brain neurotransmitter status by probiotic Escherichia coli CFR 16 secreting pyrroloquinoline quinone.Curr Microbiol. 2015 May;70(5):690-7. doi: 10.1007/s00284-014-0763-9. Epub 2015 Jan 14. Curr Microbiol. 2015. PMID: 25586077
-
Effect of methysergide on pudendal inhibition of micturition reflex in cats.Exp Neurol. 2013 Sep;247:250-8. doi: 10.1016/j.expneurol.2013.05.006. Epub 2013 May 18. Exp Neurol. 2013. PMID: 23688680 Free PMC article.
-
Human prostatic urethra expresses vitamin D receptor and responds to vitamin D receptor ligation.J Endocrinol Invest. 2010 Nov;33(10):730-8. doi: 10.1007/BF03346679. Epub 2010 Apr 12. J Endocrinol Invest. 2010. PMID: 20386089
-
Nitric oxide/cGMP-mediated effects in the outflow region of the lower urinary tract--is there a basis for pharmacological targeting of cGMP?World J Urol. 2005 Dec;23(6):362-7. doi: 10.1007/s00345-005-0019-1. Epub 2005 Nov 8. World J Urol. 2005. PMID: 16283327 Review.
-
Identification of atropine- and P2X1 receptor antagonist-resistant, neurogenic contractions of the urinary bladder.J Neurosci. 2007 Jan 24;27(4):845-51. doi: 10.1523/JNEUROSCI.3115-06.2007. J Neurosci. 2007. PMID: 17251425 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical